Our Monthly Scientific Selection: February Publications on EuroQol Instruments #2

[1-28 February 2026] 

 

  1. Stalmeier P, Rencz F, Rutjens B, Roudijk B. Unconscious death thoughts: Do they play a role in time trade-off and visual analogue scale scores for health? Qual Life Res. 2026 Feb 3.
  1. Peasgood T, De Silva Perera U, Chen G, Bailey C, Norman R, Viney R, Shah K, Devlin N; QUOKKA Project Team. Are Health Gains to Children and Adolescents More Important Than Health Gains to Adults? A Person Trade-Off Study. Pharmacoeconomics. 2026 Feb 7.
  1. Endo T, Clemens SL. Health-related quality of life among adults with chronic diseases: a linked, retrospective cohort study using the EQ-5D-5L in Queensland, Australia. Qual Life Res. 2026 Feb 12.
  1. Elgaar MG, Verstraete J, Al Sayah F, Ebeid FSE, Abbassi MM, Farid SF. Translation and cultural adaptation of the EQ-5D-Y-5L into Modern Standard Arabic for use in Egypt. J Patient Rep Outcomes. 2026 Feb 12.
  1. Metyovinyi Z, Plázár D, Becker K, Medvecz M, Rencz F. Qualitative testing of the EQ-HWB-9 with a ‘blank’ EQ-HWB VAS and EQ-5D-5L with skin bolt-ons in a rare genetic skin disease population. Qual Life Res. 2026 Feb 12.
  1. Humphries B, Ruhil A, Liu R, Pullenayegum E, Ohinmaa A, Jack SM, Xie F. Exploring the feasibility of using discrete choice experiments with duration to elicit health state preferences among Canadian youth: A convergent parallel mixed methods study. Value Health. 2026 Feb 13.
  1. Kitano T, Kurosawa N, Yoshida S. Impact of respiratory infections on health-related quality of life among children: using PedsQL, EQ-5D-Y, and EQ-TIPS. Value Health. 2026 Feb 13.
  1. McDool E, Mukuria C, Wickramasekera N, Tsuchiya A. Evaluating the validity of the EQ-HWB-9 in a large UK general population sample. Value Health. 2026 Feb 28.
Scroll To Top